NORTH AMITYVILLE, N.Y., May 3, 2018 /PRNewswire/ — Topix Pharmaceuticals, Inc. has announced the launch of Glycolix Glyco-Urea KP Therapy. This new advanced formula helps to treat severely dry skin often associated with skin conditions such as keratosis pilaris (KP), psoriasis, and dermatitis.
Thickened, cracked, itchy skin or skin plaques frequently materialize with unwanted dry skin conditions. Whether intrinsic or extrinsic, factors may strip the skin of natural amino acids and lipids, exposing skin to damage, and potentially leading to inflammation and irritation. The patented technology in KP Therapy has the ability to exfoliate dead skin cells comparable to 40% Urea, while moisturizing and replenishing the skin barrier.Continue reading “Topix Pharmaceuticals Launches Game Changing Treatment Cream For Extremely Dry Skin”